The dual IGF-1R/IR blocker, Linsitinib, modulates human orbital fibroblast activity and proliferation
AimThe insulin-like growth factor-1 receptor (IGF-1R) and its downstream signaling pathways drive proliferation, survival, and extracellular matrix production, representing key therapeutic targets in thyroid eye disease (TED). This novel in vitro study…